Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2010-12-6
pubmed:abstractText
An active angiogenesis is required for ectopic endometrial tissue growth. Our previous studies led to the identification of macrophage migration inhibitory factor (MIF), which is markedly elevated in active, vascularized, and early-stage endometriotic lesions, as a potent mitogenic factor for endothelial cells.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inducing Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD44, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation..., http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL2, http://linkedlifedata.com/resource/pubmed/chemical/DNA Primers, http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class II, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-8, http://linkedlifedata.com/resource/pubmed/chemical/Macrophage Migration-Inhibitory..., http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase..., http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A, http://linkedlifedata.com/resource/pubmed/chemical/invariant chain, http://linkedlifedata.com/resource/pubmed/chemical/p38 Mitogen-Activated Protein...
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1945-7197
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
95
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
E403-12
pubmed:meshHeading
pubmed-meshheading:20829186-Angiogenesis Inducing Agents, pubmed-meshheading:20829186-Antigens, CD44, pubmed-meshheading:20829186-Antigens, Differentiation, B-Lymphocyte, pubmed-meshheading:20829186-Biopsy, pubmed-meshheading:20829186-Chemokine CCL2, pubmed-meshheading:20829186-DNA Primers, pubmed-meshheading:20829186-Endometriosis, pubmed-meshheading:20829186-Endometrium, pubmed-meshheading:20829186-Female, pubmed-meshheading:20829186-Gene Silencing, pubmed-meshheading:20829186-Histocompatibility Antigens Class II, pubmed-meshheading:20829186-Humans, pubmed-meshheading:20829186-Interleukin-8, pubmed-meshheading:20829186-Macrophage Migration-Inhibitory Factors, pubmed-meshheading:20829186-Mitogen-Activated Protein Kinase Kinases, pubmed-meshheading:20829186-Neovascularization, Physiologic, pubmed-meshheading:20829186-Phenotype, pubmed-meshheading:20829186-RNA, Messenger, pubmed-meshheading:20829186-RNA, Small Interfering, pubmed-meshheading:20829186-RNA Interference, pubmed-meshheading:20829186-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:20829186-Signal Transduction, pubmed-meshheading:20829186-Vascular Endothelial Growth Factor A, pubmed-meshheading:20829186-p38 Mitogen-Activated Protein Kinases
pubmed:year
2010
pubmed:articleTitle
Macrophage migration inhibitory factor elicits an angiogenic phenotype in human ectopic endometrial cells and triggers the production of major angiogenic factors via CD44, CD74, and MAPK signaling pathways.
pubmed:affiliation
Centre de recherche, Hôpital Saint-François d'Assise, and Faculty de Médecine, Université Laval, 10, rue de l'Espinay, Local D0-711, Québec (Québec), Canada G1L 3L5.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't